RS-102221 (Q7277678)

RS-102221 (English)

3 October 2016

C₂₇H₃₁F₃N₄O₇S

1 reference

RS-102221 (English)

3 October 2016

COC1=CC(=C(C=C1C(=O)CCCCN2CCC3(CC2)C(=O)NC(=O)N3)NS(=O)(=O)C4=CC=C(C=C4)C(F)(F)F)OC

1 reference

RS-102221 (English)

physically interacts with

3 October 2016

5-hydroxytryptamine receptor 2A

subject has role

antagonist

1 reference

5-hydroxytryptamine receptor 2B

17 August 2016

subject has role

antagonist

1 reference

5-hydroxytryptamine receptor 2C

17 August 2016

subject has role

antagonist

1 reference

InChI=1S/C27H31F3N4O7S/c1-40-22-16-23(41-2)20(33-42(38,39)18-8-6-17(7-9-18)27(28,29)30)15-19(22)21(35)5-3-4-12-34-13-10-26(11-14-34)24(36)31-25(37)32-26/h6-9,15-16,33H,3-5,10-14H2,1-2H3,(H2,31,32,36,37)

17 August 2016

Identifiers

InChI

1 reference

RS-102221 (English)

3 October 2016

2 references

RS-102221 (English)

3 October 2016

ChEBI release 2020-09-01

CAS Registry Number

185376-97-0

1 reference

https://commonchemistry.cas.org/detail?cas_rn=185376-97-0

9 April 2021

1 reference

N-{5-[5-(2,4-Dioxo-1,3,8-triazaspiro[4.5]dec-8-yl)pentanoyl]-2,4-dimethoxyphenyl}-4-(trifluoromethyl)benzenesulfonamide (English)

3 October 2016

2 references

RS-102221 (English)

3 October 2016

ChEBI ID

93519

mapping relation type

2 references

N-[5-[5-(2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-1-oxopentyl]-2,4-dimethoxyphenyl]-4-(trifluoromethyl)benzenesulfonamide (English)

3 October 2016

International Chemical Identifier

InChI

InChI=1S/C27H31F3N4O7S/c1-40-22-16-23(41-2)20(33-42(38,39)18-8-6-17(7-9-18)27(28,29)30)15-19(22)21(35)5-3-4-12-34-13-10-26(11-14-34)24(36)31-25(37)32-26/h6-9,15-16,33H,3-5,10-14H2,1-2H3,(H2,31,32,36,37)

1 reference

RS-102,221 (English)

3 October 2016

1 reference

1 reference

1 reference

RS-102221 (English)

Human Metabolome Database ID

3 October 2016

HMDB0257336

2 references

based on heuristic

inferred from InChIKey

UNII

48D22QR8GY

1 reference